GU Podcast (2020): Immune Checkpoint Inhibitors In RCC
AUAUniversity28 Loka 2020

GU Podcast (2020): Immune Checkpoint Inhibitors In RCC

Immune Checkpoint Inhibitors in RCC At the conclusion of this activity, participants will be able to: 1. Discuss the current immunotherapy options available for the treatment of RCC. 2. Describe both completed and accruing clinical trials that are defining the paradigms of immunotherapy use in RCC. 3. Identify and manage immune related adverse events. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc Sanofi Genzyme UroGen Pharma, Inc. CME Available: https://auau.auanet.org/node/29846

Jaksot(421)

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

2016 AUA Annual Meeting Presidential Address William F. Gee, MD Lexington, KY

8 Tammi 202020min

Targeted Therapies In Renal Cell Carcinoma

Targeted Therapies In Renal Cell Carcinoma

Co-Host: Jay Raman, MD, FACS At the conclusion of these activities, participants will be able to: 1. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of...

24 Joulu 201933min

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

Co-Host: Yair Lotan, MD At the conclusion of these activities, participants will be able to: 1. Evaluate treatment plans including the sequencing and combination of treatment options for individual p...

18 Joulu 201937min

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

Co-Host: Brian M. Shuch, MD At the conclusion of these activities, participants will be able to: 1. Describe a patient-specific treatment plan that optimizes the use of targeted and immunological age...

11 Joulu 201927min

Adjuvant Therapy in Renal Cell Carcinoma

Adjuvant Therapy in Renal Cell Carcinoma

Co-Host: Alexander Kutikov, MD, FACS At the conclusion of these activities, participants will be able to: 1. Discuss the evolving landscape of adjuvant therapy for the treatment of RCC. 2. Identify b...

4 Joulu 201932min

Comorbidities in Advanced Prostate Cancer

Comorbidities in Advanced Prostate Cancer

Co-Host: Alicia K. Morgans, MD, MPH At the conclusion of these activities, participants will be able to: 1. Recognize cardiovascular comorbidities and describe their management in the context of pros...

27 Marras 201928min

Genetic Testing in Prostate Cancer

Genetic Testing in Prostate Cancer

Co-Host: Brian Shuch, MD At the conclusion of these activities, participants will be able to: 1. State the criteria for genetic testing of prostate cancer patients, the gene panels available, and opt...

18 Marras 201925min

Chemo-ablation of Upper-Tract Urothelial Carcinoma

Chemo-ablation of Upper-Tract Urothelial Carcinoma

Co-Host: Vitaly Margulis, MD At the conclusion of these activities, participants will be able to: 1. Identify new technologies for the treatment of urothelial carcinoma and analyze the risks and bene...

13 Marras 201924min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
rss-narsisti
adhd-podi
rss-liian-kuuma-peruna
rss-valo-minussa-2
aamukahvilla
jari-sarasvuo-podcast
rss-uskonto-on-tylsaa
rss-duodecim-lehti
rss-luonnollinen-synnytys-podcast
rss-arkea-ja-aurinkoa-podcast-espanjasta
rss-niinku-asia-on
kesken
salainen-paivakirja
psykologia
ihminen-tavattavissa-tommy-hellsten-instituutti
leveli
rss-tietoinen-yhteys-podcast-2